Acorah Software Products - Accounts Production 19.4.300 false true true 31 December 2024 7 April 2024 false 1 January 2025 31 December 2025 31 December 2025 15624117 Mr Thomas Garnett Mr Vladimir Galu Mr Andrew Sheffield Mr James Baker iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15624117 2024-12-31 15624117 2025-12-31 15624117 2025-01-01 2025-12-31 15624117 frs-core:CurrentFinancialInstruments 2025-12-31 15624117 frs-core:BetweenOneFiveYears 2025-12-31 15624117 frs-core:ComputerEquipment 2025-12-31 15624117 frs-core:ComputerEquipment 2025-01-01 2025-12-31 15624117 frs-core:ComputerEquipment 2024-12-31 15624117 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2025-12-31 15624117 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2025-01-01 2025-12-31 15624117 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2024-12-31 15624117 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-12-31 15624117 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 15624117 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 15624117 frs-core:WithinOneYear 2025-12-31 15624117 frs-core:OtherReservesSubtotal 2024-12-31 15624117 frs-core:OtherReservesSubtotal 2025-12-31 15624117 frs-core:SharePremium 2024-12-31 15624117 frs-core:SharePremium 2025-12-31 15624117 frs-core:ShareCapital 2025-12-31 15624117 frs-core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 15624117 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2024-12-31 15624117 frs-core:RetainedEarningsAccumulatedLosses 2025-12-31 15624117 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 15624117 frs-bus:FilletedAccounts 2025-01-01 2025-12-31 15624117 frs-bus:SmallEntities 2025-01-01 2025-12-31 15624117 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 15624117 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 15624117 frs-bus:Director1 2025-01-01 2025-12-31 15624117 frs-bus:Director2 2025-01-01 2025-12-31 15624117 frs-bus:Director3 2025-01-01 2025-12-31 15624117 frs-bus:Director4 2025-01-01 2025-12-31 15624117 frs-core:CurrentFinancialInstruments 1 2025-12-31 15624117 frs-core:CurrentFinancialInstruments 2 2025-12-31 15624117 frs-countries:EnglandWales 2025-01-01 2025-12-31 15624117 2024-04-06 15624117 2024-12-31 15624117 2024-04-07 2024-12-31 15624117 frs-core:CurrentFinancialInstruments 2024-12-31 15624117 frs-core:BetweenOneFiveYears 2024-12-31 15624117 frs-core:WithinOneYear 2024-12-31 15624117 frs-core:OtherReservesSubtotal 2024-12-31 15624117 frs-core:SharePremium 2024-12-31 15624117 frs-core:ShareCapital 2024-12-31 15624117 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 15624117 frs-core:CurrentFinancialInstruments 1 2024-12-31 15624117 frs-core:CurrentFinancialInstruments 2 2024-12-31
Registered number: 15624117
Refute Ltd
Financial Statements
For The Year Ended 31 December 2025
Applewood LLP
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—8
Page 1
Balance Sheet
Registered number: 15624117
31 December 2025 31 December 2024
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 683,023 -
Tangible Assets 5 4,666 -
687,689 -
CURRENT ASSETS
Debtors 6 269,650 8,177
Cash at bank and in hand 1,147,270 1,880,152
1,416,920 1,888,329
Creditors: Amounts Falling Due Within One Year 7 (490,580 ) (22,440 )
NET CURRENT ASSETS (LIABILITIES) 926,340 1,865,889
TOTAL ASSETS LESS CURRENT LIABILITIES 1,614,029 1,865,889
NET ASSETS 1,614,029 1,865,889
CAPITAL AND RESERVES
Called up share capital 8 139 139
Share premium account 2,329,961 2,329,961
Other reserves 40,508 -
Profit and Loss Account (756,579 ) (464,211 )
SHAREHOLDERS' FUNDS 1,614,029 1,865,889
Page 1
Page 2
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Thomas Garnett
Director
08/09/2026
The notes on pages 3 to 8 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Refute Ltd ('the Company') is a private company, limited by shares, incorporated in England & Wales, registered number 15624117 . The registered office is 78 York Street, London, W1H 1DP.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The financial statements have been prepared on the going concern basis. The Company incurred a loss after tax of £292,368 for the year ended 31 December 2025 (2024: loss of £464,211) and held cash balances of £1,147,270 at the balance sheet date.
On 15 January 2026 the Company completed a Seed funding round, raising £5,000,000 before costs (see note 11). Taking into account this fundraising and the directors' cash flow forecasts covering a period of at least twelve months from the date of approval of these financial statements, the directors are satisfied that the Company has adequate financial resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
2.3. Significant judgements and estimations
In preparing these financial statements, the directors have made the following judgements and estimates that have a significant effect on the amounts recognised in the financial statements.
Critical judgements in applying the Company's accounting policies
Capitalisation of development costs - The directors are required to assess whether internal expenditure on the development of the Company's software platform meets the criteria for capitalisation as an intangible asset under Section 18 of FRS 102. This requires judgement in distinguishing between the research phase, in which costs are expensed as incurred, and the development phase, in which costs are capitalised if the recognition criteria are met. The directors consider factors including the technical feasibility of completing the asset, the intention and ability to complete and use the asset, the availability of resources to complete development, and the expected generation of future economic benefits. 
Revenue recognition - The directors have applied judgement in identifying the performance obligations within customer contracts and in determining the timing of revenue recognition under the five-step model in Section 23 of FRS 102. In particular, judgement has been applied in determining whether services are transferred over time or at a point in time and in identifying any distinct performance obligations within bundled arrangements.
Share-based payment valuation methodology - The directors have exercised judgement in selecting the Black-Scholes option pricing model as the appropriate methodology to determine the fair value of share options granted under the Company's EMI and unapproved share option schemes, and in identifying an appropriate group of comparable listed companies from which to derive an expected volatility input, in the absence of a sufficient trading history for the Company's own shares.
Key sources of estimation uncertainty
Fair value of share-based payments - The fair value of share options granted during the year has been determined using the Black-Scholes option pricing model. The key inputs to the model include the share price at grant date, the exercise price, the expected life of the options, the risk-free rate of return, and expected volatility. The expected volatility has been estimated by reference to the historic share price volatility of a group of comparable listed companies over a period commensurate with the expected life of the options. 
Page 3
Page 4
2.4. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.5. Research and Development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research is recognised as an expense when it is incurred.
Intangible assets are recognised from the development phase of a project if, and only if, all of the following criteria are met:
- it is technically feasible to complete the asset so that it will be available for use or sale;
- there is an intention to complete the asset and use or sell it;
- there is an ability to use or sell the asset;
- the asset will generate probable future economic benefits;
- adequate technical, financial and other resources are available to complete the development and to use or sell the asset; and
- the expenditure attributable to the asset during its development can be reliably measured.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.
Capitalised development costs comprise directly attributable expenditure incurred during the development phase, including staff costs and directly attributable infrastructure costs. They are subsequently amortised to the profit and loss account on a straight line basis over their expected useful economic life of 5 years, commencing from the date the asset becomes available for use, taken as the date of the first commercial sale.
2.6. Intangible Fixed Assets and Amortisation - Intellectual Property
Intellectual property assets are Trademarks. They are amortised to the profit and loss account over their estimated economic life of 10 years.
2.7. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment Straight line over 2 years
2.8. Leasing and Hire Purchase Contracts
The Company has no finance leases or hire purchase contracts. Rentals applicable to operating leases, where substantially all of the benefits and risks of ownership remain with the lessor, are charged to the profit and loss account on a straight-line basis over the lease term.
Page 4
Page 5
2.9. Financial Instruments
The Company has chosen to apply the recognition and measurement provisions of Section 11 of FRS 102 to all of its financial instruments. Financial instruments are recognised when the Company becomes party to the contractual provisions of the instrument and are classified according to the substance of the contractual arrangements entered into.
Basic financial assets
Basic financial assets, which include trade and other receivables and cash and cash equivalents, are initially measured at transaction price, including transaction costs, and are subsequently carried at amortised cost using the effective interest method, unless the arrangement constitutes a financing transaction, in which case the financial asset is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
At the end of each reporting period, financial assets measured at amortised cost are assessed for objective evidence of impairment. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately, measured as the difference between the asset's carrying amount and the present value of the estimated future cash flows discounted at the asset's original effective interest rate.
Financial assets are derecognised when the contractual rights to the cash flows from the asset expire or are settled, or when the Company transfers to another party substantially all of the risks and rewards of ownership.
Basic financial liabilities
Basic financial liabilities, including trade and other payables and accruals, are initially measured at transaction price, net of transaction costs, and are subsequently carried at amortised cost using the effective interest method, unless the arrangement constitutes a financing transaction, in which case the financial liability is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and demand deposits, together with other short-term, highly liquid investments that are readily convertible into known amounts of cash and which are subject to an insignificant risk of changes in value.
2.10. Foreign Currencies
Functional and presentation currency
The Company's functional currency is pounds sterling (£), being the currency of the primary economic environment in which the Company operates. The financial statements are presented in pounds sterling, which is also the Company's functional currency. All amounts have been rounded to the nearest pound, except where otherwise indicated.
Foreign currency transactions
Transactions denominated in foreign currencies are translated into the functional currency at the exchange rates ruling at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are translated into the functional currency at the exchange rate ruling at that date. Exchange differences arising on translation are recognised in profit or loss in the period in which they arise.
2.11. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
...CONTINUED
Page 5
Page 6
2.11. Taxation - continued
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
2.12. Pensions
The Company operates a defined contribution pension scheme. Contributions payable to the scheme are charged to the profit and loss account in the period to which they relate.
2.13. Share based payments
The Company operates equity-settled share-based payment arrangements under an Enterprise Management Incentive (EMI) scheme and an unapproved share option scheme for qualifying employees and other service providers. The fair value of options granted is measured at the date of grant using the Black-Scholes option pricing model and is recognised as an expense in the profit and loss account on a straight-line basis over the vesting period, with a corresponding credit to other reserves. The cumulative expense recognised is adjusted to reflect the directors' best estimate of the number of options that will ultimately vest.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 5 (2024: 3)
5 3
4. Intangible Assets
Development Costs Intellectual Property Total
£ £ £
Cost
As at 1 January 2025 - - -
Additions 779,719 8,075 787,794
As at 31 December 2025 779,719 8,075 787,794
Amortisation
As at 1 January 2025 - - -
Provided during the period 103,963 808 104,771
As at 31 December 2025 103,963 808 104,771
Net Book Value
As at 31 December 2025 675,756 7,267 683,023
As at 1 January 2025 - - -
Page 6
Page 7
5. Tangible Assets
Computer Equipment
£
Cost
As at 1 January 2025 -
Additions 6,760
As at 31 December 2025 6,760
Depreciation
As at 1 January 2025 -
Provided during the period 2,094
As at 31 December 2025 2,094
Net Book Value
As at 31 December 2025 4,666
As at 1 January 2025 -
6. Debtors
31 December 2025 31 December 2024
£ £
Due within one year
Trade debtors 18,000 -
Other debtors 251,650 8,177
269,650 8,177
Other debtors include £48,198 of legal and professional costs incurred in connection with the equity fundraise that completed on 15 January 2026 (see note 11) and £163,124 relating to R&D tax credits. As the fundraising costs are directly attributable to the issue of new shares, they have been recognised as a prepayment at the reporting date and deducted from share premium on completion of the share issue post year end, in accordance with Section 22 of FRS 102.
7. Creditors: Amounts Falling Due Within One Year
31 December 2025 31 December 2024
£ £
Trade creditors 59,512 3,495
Other taxes and social security 16,432 13,289
VAT 5,404 -
Amounts received in advance of fundraise 300,000 -
Pension creditor 2,158 2,267
Accruals and deferred income 107,074 2,608
Directors' loan accounts - 781
490,580 22,440
Page 7
Page 8
Amounts received in advance of fundraise represent subscription monies of £300,000 received from investors prior to the reporting date in respect of the equity fundraise that completed on 15 January 2026 (see note 11). The corresponding shares were allotted on completion of the fundraise and the balance was reclassified from creditors to share capital and share premium at that date. The amount is presented as a basic financial liability under Section 11 of FRS 102 at the reporting date.
Accruals and deferred income include £73,461 of payments received from customers in advance of the delivery of goods and services. These amounts represent contract liabilities under Section 23 of FRS 102 and will be released to turnover as the related performance obligations are satisfied. 
8. Share Capital
31 December 2025 31 December 2024
£ £
Allotted, Called up and fully paid 139 139
9. Other Commitments
The total of future minimum lease payments under non-cancellable operating leases are as following:
31 December 2025 31 December 2024
£ £
Not later than one year 22,252 -
Later than one year and not later than five years 5,915 -
28,167 -
The Company occupies serviced office premises at 60 Gray's Inn Road, London under a two-year occupation agreement commencing 31 March 2025 and ending 30 March 2027.
10. Reserves
Share Premium Other reserves Profit and Loss Account
£ £ £
As at 1 January 2025 2,329,961 - (464,211 )
Loss for the year and total comprehensive income - - (292,368 )
Movements in other reserves - 40,508 -
As at 31 December 2025 2,329,961 40,508 (756,579 )
Other reserves represents the cumulative fair value charge recognised in respect of equity-settled share-based payment awards (see accounting policy 2.13).
11. Post Balance Sheet Events
On 15 January 2026, the Company issued ordinary and preferred shares for total consideration of £5m. This is a non-adjusting event and no adjustment has been made to these financial statements.
Page 8